202 related articles for article (PubMed ID: 10683087)
1. Short-course palliative radiotherapy in non-small-cell lung cancer: results of a prospective study.
Lupattelli M; Maranzano E; Bellavita R; Chionne F; Darwish S; Piro F; Latini P
Am J Clin Oncol; 2000 Feb; 23(1):89-93. PubMed ID: 10683087
[TBL] [Abstract][Full Text] [Related]
2. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.
Br J Cancer; 1991 Feb; 63(2):265-70. PubMed ID: 1705140
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.
Cross CK; Berman S; Buswell L; Johnson B; Baldini EH
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1098-105. PubMed ID: 15001250
[TBL] [Abstract][Full Text] [Related]
4. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Stevens R; Macbeth F; Toy E; Coles B; Lester JF
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD002143. PubMed ID: 25586198
[TBL] [Abstract][Full Text] [Related]
5. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.
Br J Cancer; 1992 Jun; 65(6):934-41. PubMed ID: 1377484
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.
Macbeth FR; Bolger JJ; Hopwood P; Bleehen NM; Cartmell J; Girling DJ; Machin D; Stephens RJ; Bailey AJ
Clin Oncol (R Coll Radiol); 1996; 8(3):167-75. PubMed ID: 8814371
[TBL] [Abstract][Full Text] [Related]
7. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
Sause WT; Scott C; Taylor S; Johnson D; Livingston R; Komaki R; Emami B; Curran WJ; Byhardt RW; Turrisi AT
J Natl Cancer Inst; 1995 Feb; 87(3):198-205. PubMed ID: 7707407
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
9. [Single-dose palliative radiotherapy in inoperable non-small-cell lung carcinoma].
Scolaro T; Bacigalupo A; Giudici S; Guenzi M; Vitale V
Radiol Med; 1995 Dec; 90(6):808-11. PubMed ID: 8685468
[TBL] [Abstract][Full Text] [Related]
10. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
Mirimanoff RO; Moro D; Bolla M; Michel G; Brambilla C; Mermillod B; Miralbell R; Alberto P
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):487-94. PubMed ID: 9806505
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and efficacy of a hypofractionated (3 weekly fractions of 850c Gy) irradiation schedule for stage IIIb / IV non-small cell lung cancer elderly patients with low performance status and unfit for chemotherapy.
Kouloulias V; Patriki E; Mosa E; Platoni K; Georgakopoulos J; Zygogianni A; Dilvoi M; Patatoukas G; Antypas C; Armpilia C; Trogkanis N; Kypraiou E; Nikoloudi S; Giannakouras G; Efstathopoulos E; Kelekis N; Kouvaris J
J BUON; 2018; 23(1):98-105. PubMed ID: 29552767
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer.
Schild SE; Stella PJ; Geyer SM; Bonner JA; Marks RS; McGinnis WL; Goetz SP; Kuross SA; Mailliard JA; Kugler JW; Schaefer PL; Jett JR
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):370-8. PubMed ID: 12243810
[TBL] [Abstract][Full Text] [Related]
14. The role of palliative thoracic radiotherapy in non-small cell lung cancer.
Brundage MD; Bezjak A; Dixon P; Grimard L; Larochelle M; Warde P; Warr D
Can J Oncol; 1996 Feb; 6 Suppl 1():25-32. PubMed ID: 8853535
[TBL] [Abstract][Full Text] [Related]
15. [Palliative radiotherapy in non-small cell bronchial carcinoma].
Slotman BJ; Njo KH; Karim AB
Ned Tijdschr Geneeskd; 1993 Oct; 137(42):2144-8. PubMed ID: 7694162
[TBL] [Abstract][Full Text] [Related]
16. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
17. Palliative thoracic radiotherapy in advanced lung cancer: A single institution experience.
Hotwani C; Agarwal JP; Prabhash K; Munshi A; Joshi A; Misra S; Kumar D; Das S; Laskar SG
Indian J Cancer; 2017; 54(1):262-266. PubMed ID: 29199702
[TBL] [Abstract][Full Text] [Related]
18. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
[TBL] [Abstract][Full Text] [Related]
19. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiotherapy in non small cell lung cancer: a review of the current literature.
Beli I; Koukourakis G; Platoni K; Tolia M; Kelekis N; Kouvaris J; Syrigos C; Mystakidou K; Varveris C; Kouloulias V
Rev Recent Clin Trials; 2010 May; 5(2):103-11. PubMed ID: 20423316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
